Illumina (ILMN) confirms shareholders voted to elect eight of nine Illumina director nominees
Illumina (NASDAQ:), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of nine Illumina director nominees – Francis deSouza,
Illumina issued the following statement:
“Illumina thanks shareholders for their continued support of the company, which remains committed to its mission of improving human health by unlocking the power of the genome. We appreciate the constructive shareholder feedback throughout this process and are committed to delivering on our plan to accelerate shareholder value creation. We will continue to provide transparent and effective communication as we move forward together.
We would like to welcome
We also thank
The company also noted that shareholders approved the proposal to ratify auditors, one-year frequency on say-on-pay, and the stock incentive plan proposal; and shareholders did not approve the company’s say-on-pay proposal.
The results announced today are considered preliminary and are subject to certification by the independent Inspector of Elections. The final certified results are expected to be provided in a Current Report filed on Form 8-K with the U.S. Securities and Exchange Commission within the next four business days.
Click Here to Read the Full Original Article at All News…